such as Alzheimer's disease (AD; n = 55) and schizophrenia (n = 28). Brodmann area 22, namely the superior temporal gyrus, had a greater number of abnormally expressed genes in both diseases ...

Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.

I want to be a companion to Sister Sheral on this journey for as long as I have breath,” Sister Maureen Sinnott writes.

Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.

It appears the effects of menopause hormone therapy on dementia risk are influenced by several factors. These include when ...

4. An person's genetic and health background The greatest genetic risk factor for older-onset Alzheimer's disease is carrying one or more copies of a specific version of the APOE gene, called APOE e4.

Gender differences define how the human brain ages, and telltale biomarkers in the blood may be strongly suggestive of cognitive impairment and dementia, according to a comprehensive new study ...

“Did I ask if your knees hurt? Are they sore? They ache?” Heltzel asked. Jordan mumbles quietly affirming some leg pain. She’s in the late stages of Alzheimer’s Disease, but the 73-year-old is also ...

Alzheimer’s disease is a progressive condition that affects memory and brain function, eventually making it hard to do even the simplest tasks. This leaves the person open to a number of ...

It has been nearly two years since my last Anavex Life Sciences (NASDAQ:AVXL) article, where I discussed ANAVEX 2-73's potential to upend the Alzheimer's Disease (AD) drug market and become a ...

Many people with Alzheimer's disease can still care for their own needs to various extents. Caring for yourself as much as possible is essential for maintaining your cognitive abilities. You can apply ...

are in a mild to early moderate range of dementia. Lecanemab first came onto the market in 2023, Jing said. But IU Health's policies require doctors with the appropriate background in medicine ...